Pharmaceutical manufacturers face a uniquely unforgiving maintenance environment — where a missed calibration record, an undocumented corrective action, or a gap in equipment qualification history can trigger an FDA Form 483 observation, a warning letter, or a consent decree. A CMMS built for pharma maintenance compliance isn't just about scheduling PMs; it's about creating tamper-evident audit trails, enforcing 21 CFR Part 11 electronic records, managing calibration lifecycles, and keeping every piece of critical manufacturing equipment in a validated, inspection-ready state. Start your free Oxmaint trial and see how leading pharma teams manage GMP compliance digitally.
Your CMMS Is Your First Line of Defense in an FDA Audit
Oxmaint gives pharma maintenance teams digital calibration logs, electronic signatures, equipment qualification records, and real-time compliance dashboards — built for 21 CFR Part 11 and GMP inspections.
Critical GMP Maintenance Capabilities — What to Look For
CMMS Compliance Requirements for Pharma — Platform Comparison
| Compliance Capability | OxMaint | Generic CMMS A | Generic CMMS B |
|---|---|---|---|
| 21 CFR Part 11 Audit Trail | Built-in, Tamper-Evident | Limited Log | No |
| Electronic Signatures (ERES) | Full 21 CFR Part 11 | Basic Login | No |
| Calibration Due Date Tracking | Automated Alerts | Manual | Limited |
| Equipment Qualification History | IQ/OQ/PQ Linked | No | No |
| Out-of-Tolerance Escalation | Automatic + CAPA Link | Manual | No |
| GMP Inspection-Ready Reports | One-Click Export | Custom BI Required | Manual Export |
| Cleanroom Protocol Templates | Pre-Built Library | No | No |
During FDA inspections, the maintenance CMMS records are reviewed with the same rigor as batch records. Investigators specifically look for gaps in calibration history, undocumented corrective actions, and evidence that equipment returned to service after repair without proper verification. I have seen Warning Letters issued primarily because the CMMS could not produce a complete, unedited maintenance history for critical manufacturing equipment. The difference between a pharmaceutical CMMS and a generic maintenance tool is 21 CFR Part 11 compliance, calibration-to-qualification linkage, and the ability to demonstrate that every maintenance decision was authorized, documented, and verified. Oxmaint's architecture was built with these requirements as design constraints, not afterthoughts.
Make Your Next FDA Inspection a Non-Event
Oxmaint gives pharma maintenance teams the audit-ready documentation, calibration tracking, and GMP workflow enforcement that turns inspection preparation from a 6-week scramble into a one-click report.






